Latest news

• Sanofi alerts US authorities over bribery allegations

  including Sanjing Pharmaceutical, Sinopharm and Shanghai Pharmaceutical.

• Roche drawn into Chinese probe into pharma

  Other companies visited by the SAIC in recent months include Roche's Swiss peer Novartis, Sanofi, AstraZeneca, Lilly and UCB, as well as several domestic drugmakers including Sanjing Pharmaceutical, Sinopharm and

• Sanjing Pharma chief leaps to his death amid corruption probe

  Other Chinese companies that have been linked to the investigation in the past include Sinopharm and Shanghai Pharmaceutical, as the government tries to put a lid on healthcare expenditure that grew

• Sinopharm executives face corruption probe in China

  Chinese authorities detained former VP Shi Jinming last week, just days after Sinopharm announced he was to step down from his role for personal reasons. ... In a statement, Sinopharm insisted the investigation would have no impact on its operations and

• GSK's Botox sales in China under scrutiny says WSJ

  multinationals such GSK, Astellas, Baxter, Boehringer Ingelheim and Merck &Co as well as domestic producers like Sinopharm Group and Jiangsu Hengrui Medicine.